S&P 500 7,376.86 +0.31%
Nasdaq 24,579.42 +1.09%
S&P/TSX 35,789.09 +0.52%
Apple 342.37 −0.52%
Nvidia 186.64 +2.78%
Microsoft 530.61 −0.99%
Shopify 210.47 +4.59%
Royal Bank 284.16 −0.59%
CAD/USD 0.7091 −0.60%
PRE-MKT · 07:20 ET
Market ClerkRecap
Mon Nov 9 · pre-market1 signal today226 insider buys this week · $429.6MCIRO short report next: Nov 15The week ahead
AE
INSIDER · RVMD · Revolution Medicines, Inc. · DIRECTOR

ANDERSON ELIZABETH M

Every open-market transaction filed under this name, Sep 22 to Sep 22.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$2M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 22RVMDRevolution Medicines, Inc.DirectorSell100$195.15$20K−2.0%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell1,500$194.59$292K−1.7%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell2,648$193.44$512K−1.1%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell4,985$192.54$960K−0.6%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell910$191.85$175K−0.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.